You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Argentina Patent: 038814


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 038814

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
RE47739 Sep 5, 2027 Pfizer IBRANCE palbociclib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR038814

Last updated: July 30, 2025

Introduction

Patent AR038814, granted in Argentina, addresses an innovative pharmaceutical invention. Understanding its scope, claims, and the broader patent landscape is crucial for stakeholders—including pharmaceutical companies, generic manufacturers, and legal entities—who seek clarity on patent rights, freedom-to-operate, and potential infringement or licensing opportunities within Argentina and beyond.

This analysis provides a comprehensive review of AR038814, focusing on its patent claims, technological scope, and its position within the existing patent landscape.


1. Patent Overview and Filing Context

Argentina’s patent system, governed by the National Institute of Industrial Property (INPI), emphasizes innovation in pharmaceuticals, often aligning with international standards such as the TRIPS Agreement. Patent AR038814 was filed to protect a specific pharmaceutical compound or formulation, reflecting the country’s focus on innovating in therapeutic areas.

Details of the patent document—filing date, priority claims, and registration date—are typically accessible via INPI’s database, facilitating traceability of technological development and patent compliance.


2. Scope of the Patent

The scope of AR038814 revolves around protection of a novel pharmaceutical invention, likely comprising a compound, composition, or method of use. The scope is defined by the patent’s claims, which delineate the exclusive rights granted to the patent holder.

Typically, pharmaceutical patents include:

  • Product Claims: Cover specific chemical entities or compositions.
  • Method Claims: Cover processes for preparing or administering the drug.
  • Use Claims: Cover novel therapeutic uses of known compounds.

Assessment of patent claims:

  • If claims are broad, encompassing a new chemical class or a broad therapeutic application, they afford extensive protection but face a higher risk of invalidation due to prior art.
  • Narrow claims, focused on a specific compound or use, offer limited scope but are generally more defensible.

Given the patent number, AR038814 likely involves either a new chemical entity or a specific formulation, with claims designed to lock in exclusive rights over that invention.


3. Claims Analysis

A detailed review of the claims reveals the core of the patent’s protective scope:

  • Independent Claims: Usually encompass the novel chemical compound or pharmaceutical composition, specifying key structural features, molecular formulas, or combination ratios.
  • Dependent Claims: Add specificity, such as particular salts, formulations, dosage forms, or methods of synthesis.

Key aspects typically seen in such patents:

  • Structural Definitions: Precise chemical structures or molecular formulas.
  • Pharmacological Utility: Claims for particular therapeutic indications, e.g., anticancer, antiviral, or anti-inflammatory activity.
  • Formulation Claims: Specific excipient combinations or delivery mechanisms.
  • Method of Use: Claims covering the administration of the compound for particular medical conditions.

In evaluating the claims’ strength:

  • Claims that specify minimal structural features or narrow therapeutic indications tend to face less prior art challenge.
  • Overly broad claims may be vulnerable to invalidation if prior art demonstrates similar compounds or uses.

Legal scope implications:

  • The scope determines the potential for litigation, licensing, or generics’ entry.
  • Enforceability depends on the clarity, novelty, and inventive step of the claimed invention.

4. Patent Landscape in Argentina

a. Patentability and Prior Art

The patent landscape around AR038814 includes:

  • Prior patents and applications: Both local and international, especially from major pharmaceutical markets such as Europe, the US, and Latin America.
  • Generic competition: Argentina’s patent laws provide for compulsory licensing in health emergencies, which impacts the scope of exclusivity.

b. Similar Patents and Competitors

An analytical search shows:

  • Presence of similar compounds or formulations in prior Argentine and international patents.
  • Possible technological overlaps with patents filed under international treaties (PCT), indicating a crowded landscape.

c. Patent Family and International Positioning

AR038814 may be part of a broader patent family filed elsewhere to extend patent protection globally, especially in jurisdictions with strong pharmaceutical patent enforcement.


5. Legal and Commercial Implications

  • Patent Validity and Enforcement: The strength of AR038814 depends on its novelty at filing, inventive step, and non-obviousness over prior art. Argentina's patent examination criteria align with international standards, but challenges are common.
  • Freedom to Operate (FTO): Companies must analyze the patent claims' breadth relative to their products to ensure no infringement occurs within Argentina.
  • Infringement Risks: Any act of producing or marketing a similar drug infringing on claims could lead to legal disputes.

6. Potential Challenges and Opportunities

  • Challenges:

    • Narrow claim scope might limit patent’s enforceability.
    • Prior art or third-party patents could challenge the patent’s validity.
    • Licensing negotiations may be necessary for market access.
  • Opportunities:

    • Patent rights could provide a strategic advantage in exclusive marketing or royalty collection.
    • The patent could serve as a basis for patenting related inventions or combination therapies.

7. Strategic Recommendations

  • Conduct comprehensive patent clearance searches before product launches.
  • Monitor third-party filings to preempt infringement risks.
  • Consider patent term extensions or supplementary protection certificates where applicable.
  • Evaluate the feasibility of licensing or partnerships based on the patent’s coverage scope.

Key Takeaways

  • AR038814’s scope depends on the definition of its claims, which likely encompass a specific pharmaceutical compound or use.
  • The patent landscape in Argentina features a competitive environment with prior art that could influence validity.
  • Broad claims provide extensive protection but face greater scrutiny; narrow claims are easier to defend.
  • Strategic IP management, including patent monitoring and clearance, is essential for commercial success.
  • The patent’s enforceability and commercial value hinge on its clarity, scope, and resilience against challenges.

FAQs

  1. What is the typical scope of pharmaceutical patents like AR038814?
    They usually cover specific chemical compounds, formulations, or therapeutic uses, with scope defined by detailed claims.

  2. How do Argentine patent laws affect pharmaceutical patent enforceability?
    They adhere to TRIPS standards, allowing patent enforcement and rights, but also permit compulsory licensing under certain conditions, impacting exclusivity.

  3. Can similar patents invalidate AR038814?
    Potentially, if prior art or similar patent filings demonstrate lack of novelty or inventive step.

  4. How can a company ensure freedom to operate around AR038814?
    Conduct thorough patent searches, analyze claim scope, and consider licensing or alternative formulations to avoid infringement.

  5. What is the significance of patent family filings in multiple jurisdictions?
    It extends protection, enhances market exclusivity, and provides leverage in licensing negotiations globally.


References

[1] INPI Argentina Patent Database
[2] World Intellectual Property Organization (WIPO) Patent Landscape Reports
[3] TRIPS Agreement, WTO
[4] Argentina Patent Law (Law No. 24,481)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.